Igc completes the final cohort of its phase 1 clinical trial on alzheimer's patients

Potomac, md.--(business wire)-- #igcad1--igc completed final cohort of phase 1 clinical trial on its thc-based investigational new drug intended to alleviate symptoms of alzheimer's disease.
IGC Ratings Summary
IGC Quant Ranking